仅对制药厂、医药研发公司、医药研究所、医院提供信息服务,不对个人提供信息服务!

类别

搜索

地點

訂閱此搜索

191.10 Dollar US$

药品名称:Revolade 25 mg 14 tab药品简介:治疗适应症Revolade适用于自诊断后持续6个月或更长时间且对其他治疗(例如皮质类固醇,免疫球蛋白)无效的1岁及以上的原发性免疫性血小板减少症(ITP)的患者的治疗。在患有慢性丙型肝炎病毒(HCV)感染的成年患者中,应发生革命性反应,以治疗血小板减少症,其中血小板减少症的程度是阻止其开始或限制维持最佳干扰素疗法的主要因素。在患有获得性严重再生障碍性贫血(SAA)的成年患者中出现了恶变,这些患者要么对先前的免疫抑制治疗无效,要么经过严格的预处理,不适合进行造血干细胞移植药品通用名:Eltrombopag厂商:NOVARTIS剂型:片...

· 十二月 27, 2019
9.90 Euro €

药品编号 13748591 持证商 URSAPHARM Arzneimittel GmbH 包装规格 10 ml 产品名 Pollival 0,5mg/ml 剂型 Augentropfen Monopräparat ja 活性物质 Azelastin hydrochlorid 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/product/pollival-0-5-mg-ml-augentropfen-loesung.645941.html

· 十一月 20, 2018
了解卖家

盐酸阿比多尔片 50mg/片,(20片/盒) Arbidol (Арбидол) Hydrochoride Tablets  持证商: Фармстандарт-Лексредства盐酸阿比多尔混悬液 25mg*5mlArbidol powder for suspension for oral administration 25mg/5ml持证商: Фармстандарт-Лексредства

Russia · 俄罗斯 九月 17, 2020
了解卖家

New Drug Application (NDA): 202408Company: ERA PHARMS LLCTreatment for: erpes Simplex Dendritic KeratitisDate of Approval:03/29/2019DrugName:AVACLYRActive Ingredients:ACYCLOVIRStrength:3%Dosage Form:OINTMENTDosage Route:OPHTHALMICTE Code:NoneRLD:YesRS:NoNDC:48102-028-35Approval Letter...

· 五月 13, 2020
了解卖家

New Drug Application (NDA): 210595Company: CIRCASSIATreatment for: Chronic Obstructive Pulmonary DiseaseDate of Approval:03/29/2019DrugName:DUAKLIR PRESSAIRActive Ingredients:ACLIDINIUM BROMIDE; FORMOTEROL FUMARATEStrength:0.4MG/INH;0.012MG/INHDosage Form:POWDER, METEREDDosage Route:I...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 022561Company: EMD SERONO INCTreatment for: Multiple SclerosisDate of Approval:03/29/2019DrugName:MAVENCLADActive Ingredients:CLADRIBINEStrength:10MG Dosage Form:TABLETDosage Route:ORALTE Code:NoneRLD:YesRS:YesNDC:44087-400-11;44087-400-12;44087-400-04;4408...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 206089Company: CLARUSTreatment for: Hypogonadism -- MaleDate of Approval:03/27/2019DrugName:JATENZOActive Ingredients:TESTOSTERONE UNDECANOATEStrength:237MGDosage Form:CAPSULEDosage Route:ORALTE Code:NoneRLD:YesRS:YesNDC:69087-237-12Start Marketing Date: 08...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 206089Company: CLARUSTreatment for: Hypogonadism -- MaleDate of Approval:03/27/2019DrugName:JATENZOActive Ingredients:TESTOSTERONE UNDECANOATEStrength:198MGDosage Form:CAPSULEDosage Route:ORALTE Code:NoneRLD:YesRS:NoNDC:69087-198-12Start Marketing Date: 08-...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 206089Company: CLARUSTreatment for: Hypogonadism -- MaleDate of Approval:03/27/2019DrugName:JATENZOActive Ingredients:TESTOSTERONE UNDECANOATEStrength:158MGDosage Form:CAPSULEDosage Route:ORALTE Code:NoneRLD:YesRS:NoNDC:69087-158-12Start Marketing Date: 08-...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 209884Company: NOVARTISTreatment for: Multiple SclerosisDate of Approval:03/26/2019DrugName:MAYZENTActive Ingredients:SIPONIMOD FUMARIC ACIDStrength:EQ 2MG BASEDosage Form:TABLETDosage Route:ORALTE Code:NoneRLD:YesRS:YesNDC: 0078-0986-15Approval Letter...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 209884Company: NOVARTISTreatment for: Multiple SclerosisDate of Approval:03/26/2019DrugName:MAYZENTActive Ingredients:SIPONIMOD FUMARIC ACIDStrength:EQ 0.25MG BASEDosage Form:TABLETDosage Route:ORALTE Code:NoneRLD:YesRS:NoNDC: 0078-0979-50Approval Lett...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 211230Company: JAZZTreatment for: Narcolepsy, Obstructive Sleep Apnea/Hypopnea SyndromeDate of Approval:03/20/2019DrugName:SUNOSIActive Ingredients:SOLRIAMFETOL HYDROCHLORIDEStrength:EQ 150MG BASEPackage:100 BottlesDosage Form:TABLETDosage Route:ORALTE Code...

· 五月 12, 2020
Top